Assessment of pulmonary surfactant in COVID-19 patients https://t.co/L5PQokyPTe
RT @ISICEM: @ISICEM 𝐂𝐫𝐢𝐭𝐢𝐜𝐚𝐥 𝐂𝐚𝐫𝐞 𝐢𝐧𝐩𝐮𝐭 : Assessment of pulmonary surfactant in #COVID19 patients #wecareintensively @jlvincen #ICUcommuni…
RT @ISICEM: @ISICEM 𝐂𝐫𝐢𝐭𝐢𝐜𝐚𝐥 𝐂𝐚𝐫𝐞 𝐢𝐧𝐩𝐮𝐭 : Assessment of pulmonary surfactant in #COVID19 patients #wecareintensively @jlvincen #ICUcommuni…
RT @ISICEM: @ISICEM 𝐂𝐫𝐢𝐭𝐢𝐜𝐚𝐥 𝐂𝐚𝐫𝐞 𝐢𝐧𝐩𝐮𝐭 : Assessment of pulmonary surfactant in #COVID19 patients #wecareintensively @jlvincen #ICUcommuni…
RT @HA_ridge: 興味深い意見 We propose that the direct effects on pulmonary tissue by SARS-CoV-2 in COVID-19 pneumonia in ARDS COVID-19 patients r…
@ISICEM 𝐂𝐫𝐢𝐭𝐢𝐜𝐚𝐥 𝐂𝐚𝐫𝐞 𝐢𝐧𝐩𝐮𝐭 : Assessment of pulmonary surfactant in #COVID19 patients #wecareintensively @jlvincen #ICUcommunity #CriticalCare #Intensivecare #FOAMed #FOAMcc https://t.co/z0YZs1evi4
興味深い意見 We propose that the direct effects on pulmonary tissue by SARS-CoV-2 in COVID-19 pneumonia in ARDS COVID-19 patients resembles neonatal respiratory distress syndrome (NRDS), caused by surfactant deficiency. https://t.co/zCHJ4dxlZu